GMP Excellence: VIVEbiotech Continues Advancing High-Quality Lentiviral Vector Manufacturing
Our Qualified Person & Regulatory Affairs Director, Rakel Lopez de Maturana, shares how quality guides every step of our GMP-certified lentiviral vector manufacturing processes.
At VIVEbiotech, quality is an integral part of who we are and how we operate. Since we first obtained our GMP certification in 2017, we have consistently demonstrated our commitment to ensuring the highest standards in the manufacturing of lentiviral vectors.
Our GMP accreditation—renewed multiple times and most recently extended in 2025—ensures that every stage of our manufacturing process is well controlled, consistent, and aligned with the most rigorous requirements. This certification covers both active pharmaceutical ingredient (API) and drug product (DP), supporting reliability across the entire workflow.
In this video, our Qualified Person & Regulatory Affairs Director, Rakel Lopez de Maturana, reflects on what quality truly means at VIVEbiotech and how our team works every day to ensure excellence in efficacy, safety, and reliability for every batch we produce and release.
We continue to work closely with regulatory authorities and clients to support excellence in lentiviral vector manufacturing. Our commitment remains clear: delivering high-quality lentiviral vectors that meet the expectations of our clients and the patients they serve.
Follow us on LinkedIn to stay updated on our latest news and developments.